Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to irritable: Irritable Male Syndrome
References in periodicals archive ?
Key Words: Irritable bowel syndrome, Generalized anxiety disorder, Medical students
All the patients with diarrhea-predominant irritable bowel syndrome (IBS-D) were found to have the same kind of exhaustion in their T-cells.
FIGURE 3 harmacologic therapies for irritable bowel syndrome by symptom (13,14) Abdominal pain/-discomfort ** Antidepressants * (TCAs/SSRIs) ** Alosetron (5-THE antagonist) ** Dicyclomine ** Hyoscyamine * Constipation ** Fiber * ** MOM/PEG solution * ** Linaclotide (guanylate Cyclase-C agonist Bloating ** Rifaximin ** Probiotics * Diarrhea ** Loperamide * ** Diphenoxylate-astropine * ** Cholestyramine * ** Alosetron ** Rifaximin ** Eluxadoline * Not currently approved by the US Food and Drug Administration for the treatment of irritable bowel syndrome.
This report provides comprehensive information on the therapeutic development for Irritable Bowel Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Pharmaceutical company Allergan (NYSE:AGN) reported on Monday the launch of its first-in-class proactive treatment VIBERZI (eluxadoline) for irritable bowel syndrome with diarrhea (IBS-D) through prescription in the US.
M2 PHARMA-December 15, 2015-Allergan unveils first-in-class proactive treatment VIBERZI in the US for irritable bowel syndrome with diarrhea (IBS-D)
El sindrome del colon irritable es un trastorno que afecta los intestinos.
Blastocystis hominis has also been incriminated to play a role in functional bowel disorders such as irritable bowel syndrome.
ClickPress, Tue Aug 04 2015] Global Markets Direct's, 'Irritable Bowel Syndrome - Pipeline Review, H1 2015', provides an overview of the Irritable Bowel Syndrome's therapeutic pipeline.
Thirty Australian patients (mean age, 41 years) with irritable bowel syndrome were randomly assigned to consume a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs; less than 0.